Submit Deal

BIRD ROCK BIO

Summary

Bird Rock Bio is a clinical stage biopharmaceutical company focused on developing innovative immuno-inflammatory regulators.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 16 M

Avg. Deal Size£ 16 M

Market Context

Senior Management

Sort

Target: BIRD ROCK BIO

Bidder: SKYE BIOSCIENCE

4 Service Providers

19 Dealmakers

£ 15 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy